ZT 386
Alternative Names: ZT-386Latest Information Update: 10 Nov 2006
At a glance
- Originator Nippon Zeon; Taisho Pharmaceutical
- Class Antiasthmatics
- Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 10 Nov 2006 Discontinued - Preclinical for Asthma in Japan (unspecified route)
- 01 Jul 1998 No-Development-Reported for Asthma in Japan (Unknown route)
- 28 Oct 1994 Preclinical development for Asthma in Japan (Unknown route)